• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于检测缺血性心肌病患者心肌存活能力的机电标测

Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy.

作者信息

Bøtker H E, Lassen J F, Hermansen F, Wiggers H, Søgaard P, Kim W Y, Bøttcher M, Thuesen L, Pedersen A K

机构信息

Department of Cardiology, Skejby Hospital, Aarhus, Denmark.

出版信息

Circulation. 2001 Mar 27;103(12):1631-7. doi: 10.1161/01.cir.103.12.1631.

DOI:10.1161/01.cir.103.12.1631
PMID:11273989
Abstract

BACKGROUND

We evaluated the ability of electromechanical mapping of the left ventricle to distinguish between nonviable and viable myocardium in patients with ischemic cardiomyopathy.

METHODS AND RESULTS

Unipolar voltage amplitudes and local endocardial shortening were measured in 31 patients (mean+/-SD age, 62+/-8 years) with ischemic cardiomyopathy (ejection fraction, 30+/-9%). Dysfunctional regions, identified by 3D echocardiography, were characterized as nonviable when PET revealed matched reduction of perfusion and metabolism and as viable when perfusion was reduced or normal and metabolism was preserved. Mean unipolar voltage amplitudes and local shortening differed among normal, nonviable, and viable dysfunctional segments. Coefficient of variation for local shortening exceeded differences between groups and did not allow distinction between normal and dysfunctional myocardium. Optimum nominal discriminatory unipolar voltage amplitude between nonviable and viable dysfunctional myocardium was 6.5 mV, but we observed a great overlap between groups. Individual cutoff levels calculated as a percentage of electrical activity in normal segments were more accurate in the detection of viable dysfunctional myocardium than a general nominal cutoff level. The optimum normalized discriminatory value was 68%. Sensitivity and specificity were 78% for the normalized discriminatory value compared with 69% for the nominal value (P:<0.02).

CONCLUSIONS

Endocardial ECG amplitudes in patients with ischemic cardiomyopathy display a wide scatter, complicating the establishment of exact nominal values that allow distinction between viable and nonviable areas. Individual normalization of unipolar voltage amplitudes improves diagnostic accuracy. Electroanatomic mapping may enable identification of myocardial viability.

摘要

背景

我们评估了左心室机电标测在区分缺血性心肌病患者非存活心肌和存活心肌方面的能力。

方法与结果

对31例(平均年龄±标准差,62±8岁)缺血性心肌病患者(射血分数,30±9%)测量单极电压幅度和局部心内膜缩短情况。经三维超声心动图确定的功能障碍区域,当PET显示灌注和代谢匹配性降低时被判定为非存活心肌,当灌注降低或正常且代谢保留时被判定为存活心肌。正常、非存活和存活功能障碍节段的平均单极电压幅度和局部缩短情况有所不同。局部缩短的变异系数超过了组间差异,无法区分正常心肌和功能障碍心肌。非存活和存活功能障碍心肌之间的最佳名义鉴别单极电压幅度为6.5 mV,但我们观察到组间存在很大重叠。以正常节段电活动百分比计算的个体截断水平在检测存活功能障碍心肌方面比一般名义截断水平更准确。最佳归一化鉴别值为68%。归一化鉴别值的敏感性和特异性为78%,而名义值为69%(P<0.02)。

结论

缺血性心肌病患者的心内膜心电图幅度呈现广泛离散,使得建立能够区分存活和非存活区域的精确名义值变得复杂。单极电压幅度的个体归一化提高了诊断准确性。电解剖标测可能有助于识别心肌存活情况。

相似文献

1
Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy.用于检测缺血性心肌病患者心肌存活能力的机电标测
Circulation. 2001 Mar 27;103(12):1631-7. doi: 10.1161/01.cir.103.12.1631.
2
Electromechanical mapping for detecting myocardial viability and ischemia in patients with severe ischemic cardiomyopathy.用于检测严重缺血性心肌病患者心肌存活性和缺血情况的机电标测。
Am J Cardiol. 2003 Apr 1;91(7):807-11. doi: 10.1016/s0002-9149(03)00013-4.
3
Electromechanical mapping versus positron emission tomography and single photon emission computed tomography for the detection of myocardial viability in patients with ischemic cardiomyopathy.缺血性心肌病患者中心肌存活检测的心脏电机械标测与正电子发射断层扫描及单光子发射计算机断层扫描的比较
J Am Coll Cardiol. 2003 Mar 5;41(5):843-8. doi: 10.1016/s0735-1097(02)02961-3.
4
Unipolar voltage abnormality is associated with greater left ventricular dysfunction in ischemic cardiomyopathy.单极电压异常与缺血性心肌病中更严重的左心室功能障碍相关。
J Cardiovasc Electrophysiol. 2014 Mar;25(3):293-8. doi: 10.1111/jce.12315. Epub 2013 Dec 4.
5
Online myocardial viability assessment in the catheterization laboratory via NOGA electroanatomic mapping: Quantitative comparison with thallium-201 uptake.通过NOGA电解剖标测在导管室进行在线心肌存活性评估:与铊-201摄取的定量比较。
Circulation. 2001 Aug 28;104(9):1005-11. doi: 10.1161/hc3401.095099.
6
Fundamental differences in electrophysiologic and electroanatomic substrate between ischemic cardiomyopathy patients with and without clinical ventricular tachycardia.有临床室性心动过速和无临床室性心动过速的缺血性心肌病患者在电生理和电解剖基质方面的根本差异。
J Am Coll Cardiol. 2009 Jul 7;54(2):166-73. doi: 10.1016/j.jacc.2009.04.024.
7
Why do patients with ischemic cardiomyopathy and a substantial amount of viable myocardium not always recover in function after revascularization?为什么患有缺血性心肌病且有大量存活心肌的患者在血运重建后功能并非总能恢复?
J Thorac Cardiovasc Surg. 2004 Feb;127(2):385-90. doi: 10.1016/j.jtcvs.2003.08.005.
8
Association between High Endocardial Unipolar Voltage and Improved Left Ventricular Function in Patients with Ischemic Cardiomyopathy.缺血性心肌病患者的心内膜单极电压升高与左心室功能改善之间的关联。
Tex Heart Inst J. 2016 Aug 1;43(4):291-6. doi: 10.14503/THIJ-15-5341. eCollection 2016 Aug.
9
Comparison between left ventricular electromechanical mapping and radionuclide perfusion imaging for detection of myocardial viability.左心室心肌电机械标测与放射性核素灌注成像在检测心肌存活方面的比较。
Circulation. 1998 Nov 3;98(18):1837-41. doi: 10.1161/01.cir.98.18.1837.
10
Electromechanical properties of perfusion/metabolism mismatch: comparison of nonfluoroscopic electroanatomic mapping with 18F-FDG PET.灌注/代谢不匹配的机电特性:非荧光透视电解剖标测与18F-FDG PET的比较
J Nucl Med. 2004 Oct;45(10):1611-8.

引用本文的文献

1
Coronary Guidewires in Temporary Cardiac Pacing and Assessment of Myocardial Viability: Current Perspectives and Future Directions.冠状动脉导丝在临时心脏起搏及心肌活力评估中的应用:当前观点与未来方向
J Clin Med. 2023 Nov 8;12(22):6976. doi: 10.3390/jcm12226976.
2
Left ventricular electrical potential measured by the NOGA XP electromechanical mapping method as a predictor of response to cardiac resynchronization therapy.采用NOGA XP 机电标测法测量左心室电位作为心脏再同步治疗反应的预测指标。
Front Cardiovasc Med. 2023 May 4;10:1107415. doi: 10.3389/fcvm.2023.1107415. eCollection 2023.
3
Myocardial stunning and hibernation revisited.
心肌顿抑和冬眠再探讨。
Nat Rev Cardiol. 2021 Jul;18(7):522-536. doi: 10.1038/s41569-021-00506-7. Epub 2021 Feb 2.
4
Contact-force monitoring increases accuracy of right ventricular voltage mapping avoiding "false scar" detection in patients with no evidence of structural heart disease.接触力监测可提高右心室电压标测的准确性,避免在无结构性心脏病证据的患者中检测到“假性瘢痕”。
Indian Pacing Electrophysiol J. 2020 Nov-Dec;20(6):243-249. doi: 10.1016/j.ipej.2020.07.004. Epub 2020 Aug 6.
5
Cellular Therapy for Heart Failure.心力衰竭的细胞治疗
Curr Cardiol Rev. 2016;12(3):195-215. doi: 10.2174/1573403x12666160606121858.
6
Pre to Intraoperative Data Fusion Framework for Multimodal Characterization of Myocardial Scar Tissue.术前至术中数据融合框架,用于心肌瘢痕组织的多模态特征描述。
IEEE J Transl Eng Health Med. 2014 Sep 4;2:1900211. doi: 10.1109/JTEHM.2014.2354332. eCollection 2014.
7
Myocardial viability assessment: poor correlation between electromechanical cardiac mapping and positron emission tomography in severe coronary artery disease.心肌存活性评估:严重冠状动脉疾病中的心机电图与正电子发射断层扫描之间的相关性较差。
Neth Heart J. 2005 Sep;13(9):305-311.
8
Positron emission tomography for the assessment of myocardial viability: an evidence-based analysis.用于评估心肌活力的正电子发射断层扫描:一项基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(16):1-167. Epub 2005 Oct 1.
9
Myocardial viability: what we knew and what is new.心肌存活性:既往所知与新进展。
Cardiol Res Pract. 2012;2012:607486. doi: 10.1155/2012/607486. Epub 2012 Sep 5.
10
Emerging roles for integrated imaging modalities in cardiovascular cell-based therapeutics: a clinical perspective.新兴的综合影像模式在心血管细胞治疗中的作用:临床视角。
Eur J Nucl Med Mol Imaging. 2012 Jan;39(1):165-81. doi: 10.1007/s00259-011-1925-7. Epub 2011 Sep 8.